Lastest Financial Results

Feb 16, 2021 • 5:30 PM EST

Q3 2021 Quarterly Results

Quarter Ended Dec 31, 2020

Latest Annual Filing

Fiscal Year Ended Mar 31, 2020

View Filing

Stock Information

Company Overview

Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. The company's products, which are sold throughout the world, have improved outcomes for more than ten million patients globally by reducing infection, itch, pain, scarring and harmful inflammatory responses. Sonoma’s headquarters are in Petaluma, California, with manufacturing operations in both the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands.

Investor Presentation Jan 2021

Investor Presentation Jan 2021

Download Investor Presentation Jan 2021


Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information


Sonoma Pharmaceuticals, Inc.
645 Molly Lane
Suite 150
Woodstock, GA 30189

Investor Relations

T: 707-559-7380

Transfer Agent

462 South 4th Street
Suite 1600
Louisville, KY 40202
T: 888-647-8901